Avenue Therapeutics, Inc. (ATXI)
0.54
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Avenue Therapeutics Total Liabilities (Quarterly) : 1.407M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.407M |
| March 31, 2026 | 1.27M |
| December 31, 2025 | 1.099M |
| September 30, 2025 | 1.422M |
| June 30, 2025 | 1.329M |
| March 31, 2025 | 1.262M |
| December 31, 2024 | 0.816M |
| September 30, 2024 | 0.973M |
| June 30, 2024 | 1.161M |
| March 31, 2024 | 1.412M |
| December 31, 2023 | 1.196M |
| September 30, 2023 | 5.024M |
| June 30, 2023 | 7.812M |
| March 31, 2023 | 10.60M |
| December 31, 2022 | 3.579M |
| September 30, 2022 | 0.614M |
| June 30, 2022 | 0.407M |
| March 31, 2022 | 0.797M |
| December 31, 2021 | 0.509M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.848M |
| June 30, 2021 | 0.549M |
| March 31, 2021 | 0.469M |
| December 31, 2020 | 0.886M |
| September 30, 2020 | 1.118M |
| June 30, 2020 | 1.23M |
| March 31, 2020 | 0.923M |
| December 31, 2019 | 2.115M |
| September 30, 2019 | 1.917M |
| June 30, 2019 | 1.773M |
| March 31, 2019 | 9.412M |
| December 31, 2018 | 5.156M |
| September 30, 2018 | 2.469M |
| June 30, 2018 | 4.419M |
| March 31, 2018 | 5.92M |
| December 31, 2017 | 2.79M |
| September 30, 2017 | 1.99M |
| June 30, 2017 | 7.549M |
| March 31, 2017 | 9.138M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.976M |
| Shareholders Equity (Quarterly) | 0.569M |
| Current Ratio | 1.404 |